Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 公司是一家高科技生物制药上市企业。我武只发展具有重大技术优势或市场优势的创新药物(包括疗效确切的中药或天然药物、干细胞药物)或具有同类医药功能的产品、新医疗器械,并且独立研发,投资或并购符合此述标准的技术、产品或企业,拥有包括但不限于专利保护的市场地位,是公司基本的产品发展策略。 | ||||||||||||||||||||||||
Main Business | 研发、生产和销售变应原制品 | ||||||||||||||||||||||||
Legal Representative | 胡赓熙 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 管祯玮 | ||||||||||||||||||||||||
Solicitors | 通力律师事务所 | ||||||||||||||||||||||||
Auditors | 立信会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 021-64852611;0572-8350682 | ||||||||||||||||||||||||
Fax No | 021-64854050;572-8831006 | ||||||||||||||||||||||||
Website | www.wolwobiotech.com | ||||||||||||||||||||||||
Invest@wolwobiotech.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 21/01/2014 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.592 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.185 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 4.173 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 12.048B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |